Company Filing History:
Years Active: 2000
Title: Innovations of Paul Senn in Chemiluminescent Energy Transfer Conjugates
Introduction
Paul Senn is an accomplished inventor based in Bennwil, Switzerland. He has made significant contributions to the field of chemiluminescent energy transfer conjugates. His innovative work has led to the development of new compounds that have practical applications in biological labeling.
Latest Patents
Paul Senn holds a patent for "Chemiluminescent energy transfer conjugates and their uses as labels." This patent describes a new class of chemiluminescent acridinium or benzacridinium compounds. The invention involves forming an intramolecular energy transfer conjugate (ETC) between the acridinium or benzacridinium compound and a luminophore. The method allows for the extension of emission wavelengths, reducing spectral overlap between different compounds. The ETCs maintain the unique properties of acridinium or benzacridinium compounds, including rapid light emission, a monophasic emission spectrum, and good stability. The invention also includes chemiluminescent labeled conjugates that can be used in binding assays and test kits.
Career Highlights
Paul Senn is associated with Bayer Corporation, where he has been able to apply his expertise in chemiluminescence. His work has contributed to advancements in the field, particularly in the development of labeling techniques for biological molecules.
Collaborations
Paul has collaborated with notable coworkers, including Qingping Jiang and Jun Xi. Their combined efforts have furthered research and development in the area of chemiluminescent compounds.
Conclusion
Paul Senn's innovative work in chemiluminescent energy transfer conjugates has opened new avenues for biological labeling and research applications. His contributions continue to impact the scientific community positively.